about
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standardsSuppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cellsProtein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTLProtocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicityDendritic cells promote pancreatic viability in mice with acute pancreatitis.MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cellsIdentification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model.CD8(+) T-cell Immune Evasion Enables Oncolytic Virus ImmunotherapyConstitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.Suppression of T cell responses in the tumor microenvironment.Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma.Defective adhesion in tumor infiltrating CD8+ T cells.Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.Tumors antigens encoded by oncogenes and the impact of oncogenes upon the immune responses.Study of immune response to tumors in the rat.Myeloid suppressor cells regulate the adaptive immune response to cancer.Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction.The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8+ T-cell Function.Soluble proteins isolated from Borrelia burgdorferi by extraction with Triton X-114 confer resistance to experimental infection.Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine photolabels a substrate-binding site of rat hepatic cytochrome P-450 form PB-4.Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.Induction of cytochrome P-450 isozymes in rat hepatoma-derived cell culturesRat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppressionRole of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762Location of a gelatin-binding region of human plasma fibronectinStudies on the biosynthesis of microsomal membrane proteins. Site of synthesis and mode of insertion of cytochrome b5, cytochrome b5 reductase, cytochrome P-450 reductase and epoxide hydrolaseDominant-negative p53 can restore tumorigenicity of L-929 cells in immunocompetent miceExpression of activated H-rasval12 in nontumorigenic and non-cross-reactive syngeneic cells induces tumor antigens cross-reactive with rat mammary adenocarcinoma 13762Studies on the subunit composition of rat liver glutathione S-transferasesApparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cellsKilling of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II moleculesMice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivoCD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ
P50
Q26744395-FAA00294-196E-4F5C-ADD3-55B080B10CF5Q30418212-06473715-66C1-4960-8C73-D2661D05D779Q30541527-4FC83A6D-9BB0-49C6-BDFF-E4BAB5E9880AQ34261705-04FDE4E2-F52C-41AA-9AC8-2F31C86BD8B9Q35057789-509E1043-6F8F-4FCB-BC55-47A02344AAB3Q35457197-1E77CDA0-3353-4E9A-BFEE-F6799B61D12AQ36193536-21BEE85C-7000-41AC-A44B-5BDAD0531211Q36278051-0516D815-6493-4645-83CC-814C904A3532Q36741859-83D1A851-8C25-41FC-9C08-524CBAEF6B9BQ36753953-4025A054-06A0-4063-BEEC-2535620DF22FQ37072024-08CEBFD8-96FF-45E3-81F9-155D39EAE9DFQ37403094-AC1C204A-14C7-407F-A990-D96F6C5F0238Q38592360-552232CC-414E-4763-95D2-3F0EA17FC0E0Q39970527-653F8223-4AFD-4BD0-9EA3-B5DFDD110E26Q40164311-DA845F5A-4074-4454-B4B8-368C753DC49EQ40284391-F0D8F18E-7CC1-4B63-8526-7105DED523F6Q40460783-43148785-8789-42D4-88BB-8A2588D63FC4Q40975372-1DB7C8C1-1B14-493A-93D5-B1997BFD96F3Q41004376-176AA7C1-6242-45E0-8B82-B710EC138E88Q41498369-8B0AD34B-BA2B-4AB2-864A-F74FEBEB6EA6Q43259754-190979F9-2298-4A0B-BEE2-F341FE732940Q43792267-F8077D74-BB72-4C5B-99FB-34BC65E2F197Q45160252-6B01D17C-BF63-4778-BBBC-95ED5FCC568BQ50219856-A2456956-DF0E-4932-A78D-A82C450C6278Q54123185-907F45F9-CFAE-47B4-9282-C747A2656695Q54173682-31A5A993-7D4A-48C0-BF87-64FEE3E83DD1Q54423911-6489E654-6CE7-4604-AA23-8352B16ACB0FQ55051893-DDFA5AD7-C703-4ABD-A5B3-184E1BDA8226Q70368721-D781A86F-C17C-447C-A07C-890C8236D8F1Q70489840-74CD0FD5-CC38-41D3-9A2F-0034BD8850DBQ71059441-E88F96AF-871D-481D-BDE8-32FB34008D41Q71185800-98CF53F9-5345-46E4-8136-C46D3106F71FQ71589331-2CA084FB-A715-4DD5-82CC-D4D3B4F4980BQ71820075-A1ADD314-785C-4D2F-AC66-3536BA9223D0Q71829003-0FD2E39D-94FE-4A12-9207-FAE25DF67B77Q71829748-604B623E-21F0-4484-A8D9-FF841586B4E1Q72260685-3DF74F3D-E850-4AC4-A7AA-E33006109D46Q73418846-26BF5E43-B7D8-40F9-AEEA-1540331CC62BQ73458466-72929006-F7A2-4912-A0B3-1270B6D08B07Q73850530-DA8B4C17-2207-4FA0-B1E6-5CAB5A7D38F1
P50
description
researcher ORCID ID = 0000-0003-4151-561X
@en
wetenschapper
@nl
name
Alan B Frey
@ast
Alan B Frey
@en
Alan B Frey
@es
Alan B Frey
@nl
type
label
Alan B Frey
@ast
Alan B Frey
@en
Alan B Frey
@es
Alan B Frey
@nl
prefLabel
Alan B Frey
@ast
Alan B Frey
@en
Alan B Frey
@es
Alan B Frey
@nl
P106
P21
P31
P496
0000-0003-4151-561X